Friday, September 22, 2023
Clinical Advances in
Read Overview
Supported by independent funding from
Novartis
Associate Professor for Internal Medicine and Rheumatology
Ruhr-University Bochum
Bochum, Germany
Professor of Medicine
Oregon Health & Science University
Portland, Oregon, United States
Clinical Professor of Dermatology
Medical Director
Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Foundation Professor of Dermatology
University of Manchester
Manchester, United Kingdom
Professor
University of Glasgow
Glasgow, United Kingdom
Professor and Waldman Chair
Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Professor of Dermatological Allergology
Director of Research
Clinic for Dermatology, Venerology and Allergology
Charité University Medicine
Berlin, Germany
Has no relevant financial relationships.
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Abbvie; Amgen; Aurinia; Bristol Myers Squibb; Celgene; Eli Lilly and Company; GlaxoSmithKline; Janssen; MoonLake; Novartis; Pfizer; UCB
Served as a speaker or a member of a speakers bureau for: Janssen; Novartis; Pfizer; UCB
Received grants for clinical research from: Abbvie; Bristol Myers Squibb; Celgene; Eli Lilly and Company; GlaxoSmithKline; Novartis; Pfizer; UCB
Has no relevant financial relationships.
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Bristol Myers Squibb; Boehringer Ingelheim; Dermavant; Eli Lilly and Company; GlaxoSmithKline
Served as a speaker or a member of a speakers bureau for: Abbvie; Almirall; Bristol Myers Squibb; Boehringer Ingelheim; Eli Lilly and Company; Janssen; Novartis
Received grants for clinical research from: Abbvie; Almirall; Amgen; Eli Lilly and Company; Novartis; Roche; Sanofi; UCB BioPharma; Walgreens Boots Alliance
Owns stock, stock options, or bonds from: CGSkin plc
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Abbvie; AstraZeneca; Bristol Myers Squibb; Cabaletta Causeway; Compugen; Eli Lilly and Company; Gilead; GlaxoSmithKline; Janssen; Moonlake; Novartis; Sanofi; SciRhom; UCB
Served as a speaker or a member of a speakers bureau for: Abbvie; UCB
Received grants for clinical research from: Amgen; AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb; Eli Lilly and Company; UCB
Owns stock, stock options, or bonds from: Causeay Therapeutics
Other: Calbetta; Compugen; Causway Therapeutics; Evelo; Step Pharma
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AnaptysBio; Arcutis Inc.; Arena Pharmaceuticals; Aristea Therapeutics; Avotres Therapeutics; BioMX; Boehringer Ingelheim; Brikell Biotech; Castle Biosciences; Corevitas; Dermavant Sciences; Evommune, Inc. Facilitatation of Internal Dermatology Education; Forte Biosciences; Foundation for Research and Education in Dermatology; Hexima Ltd.; Meiji Seika Pharma; Mindera; Pfizer; Seanergy; Verrica
Received grants for clinical research from: Abbvie; Amgen; Arcutis; Avotres; Boehringer Ingelheim; Cara Therapeutics; Dermavant Sciences; Eli Lilly and Company; Incyte; Inozyme; Janssen Research & Development, LLC; Novartis; Ortho Dermatologics; Regeneron; UCB Inc.
Has disclosed the following relevant financial relationships:
Contracted researcher for: ArgenX; AstraZeneca; BioCryst; Bluepring; Celldex; CSL Behring; Eli Lilly and Company; Dyax; FAES; Genetech; GIInnovation; Kalvista; Kyowa Kirin; Leo Pharma; Menarini; Moxie; Novartis; Pharming Pharvaris; Roche; Sanofi/Regeneron; Shire/Takeda; Third Hamonicbio; UCB; Uriach
Served as an advisor or consultant for: Allakos; Amgen; AregenX; AstraZeneca; BioCryst; Blueprint; Celldex; CSL Behring; Eli Lilly and Company; Dyax; FAES; Genetech; GIInnovation; Kalvista; Kyowa Kirin; Leo Pharma; Menarini; Moxie; Novartis; Pharming Pharvaris; Roche; Sanofi/Regeneron; Shire/Takeda; Third Hamonicbio; UCB; Uriach
Served as a speaker or a member of a speakers bureau for: BioCryst; Celldex; CSL Behring; FAES; Manarini; Novartis; Sanofi/Regeneron; Shire/Takeda; Uriach
Received grants for clinical research from: Allakos; Amgen; AregenX; AstraZeneca; BioCryst; Blueprint; Celldex; CSL Behring; Eli Lilly and Company; Dyax; FAES; Genetech; GIInnovation; Kalvista; Kyowa Kirin; Leo Pharma; Menarini; Moxie; Novartis; Pharming Pharvaris; Roche; Sanofi/Regeneron; Shire/Takeda; Third Hamonicbio; UCB; Uriach
